Focus: Haemonetics is a Boston-based biotechnology company specializing in blood management solutions, serving cardiovascular, oncology, and infectious disease markets with diagnostic and therapeutic platforms.
Profile data last refreshed 8h ago · AI intelligence enriched 2mo ago
Hot — 115 jobs added in 30d
Net +67 (115 new, 48 removed). Aggressive expansion phase.
Strong niche positioning in blood management with legitimate clinical programs, but opaque financial health and zero active recruitment create uncertainty for career growth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Haemonetics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Haemonetics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo